Drug Shortage Report for TEVA-PREDNISOLONE
Report ID | 86933 |
Drug Identification Number | 00700401 |
Brand name | TEVA-PREDNISOLONE |
Common or Proper name | PREDNISOLONE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PREDNISOLONE ACETATE |
Strength(s) | 1% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01BA |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-06-18 |
Estimated end date | 2019-07-30 |
Actual end date | 2019-07-30 |
Shortage status | Resolved |
Updated date | 2019-08-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-06-18 | English | Compare |
v2 | 2019-06-18 | French | Compare |
v3 | 2019-06-19 | English | Compare |
v4 | 2019-07-15 | English | Compare |
v5 | 2019-07-15 | French | Compare |
v6 | 2019-08-06 | English | Compare |
v7 | 2019-08-06 | French | Compare |
Showing 1 to 7 of 7